<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Life sciences briefing: Friday, Aug. 31, 2007</title>
	<atom:link href="http://venturebeat.com/2007/08/31/life-sciences-briefing-friday-aug-31-2007/feed/" rel="self" type="application/rss+xml" />
	<link>http://venturebeat.com/2007/08/31/life-sciences-briefing-friday-aug-31-2007/</link>
	<description>News About Tech, Money and Innovation</description>
	<lastBuildDate>Tue, 24 Nov 2009 06:27:18 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: VentureBeat &#187; Life sciences briefing: Wednesday, Oct. 24, 2007</title>
		<link>http://venturebeat.com/2007/08/31/life-sciences-briefing-friday-aug-31-2007/comment-page-1/#comment-593980</link>
		<dc:creator>VentureBeat &#187; Life sciences briefing: Wednesday, Oct. 24, 2007</dc:creator>
		<pubDate>Wed, 24 Oct 2007 17:40:43 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/08/31/life-sciences-briefing-friday-aug-31-2007/#comment-593980</guid>
		<description>[...] Aryx reengineers existing drugs, many with safety problems, in order to revive them or to sidestep complications. It now plans to offer up to 5.75 million shares at a price of $14 to $16 per share. Our previous coverage of the company and its strategy is here. [...]</description>
		<content:encoded><![CDATA[<p>[...] Aryx reengineers existing drugs, many with safety problems, in order to revive them or to sidestep complications. It now plans to offer up to 5.75 million shares at a price of $14 to $16 per share. Our previous coverage of the company and its strategy is here. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Aryx aims to raise $86M in IPO for rejiggered drugs</title>
		<link>http://venturebeat.com/2007/08/31/life-sciences-briefing-friday-aug-31-2007/comment-page-1/#comment-502238</link>
		<dc:creator>VentureBeat &#187; Aryx aims to raise $86M in IPO for rejiggered drugs</dc:creator>
		<pubDate>Fri, 31 Aug 2007 18:00:57 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/08/31/life-sciences-briefing-friday-aug-31-2007/#comment-502238</guid>
		<description>[...] our story on this Fremont, Calif., biotech in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</description>
		<content:encoded><![CDATA[<p>[...] our story on this Fremont, Calif., biotech in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Aryx aims to raise $86M in IPO for rejiggered drugs</title>
		<link>http://venturebeat.com/2007/08/31/life-sciences-briefing-friday-aug-31-2007/comment-page-1/#comment-502252</link>
		<dc:creator>VentureBeat &#187; Aryx aims to raise $86M in IPO for rejiggered drugs</dc:creator>
		<pubDate>Fri, 31 Aug 2007 18:00:57 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/08/31/life-sciences-briefing-friday-aug-31-2007/#comment-502252</guid>
		<description>[...] our story on this Fremont, Calif., biotech in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</description>
		<content:encoded><![CDATA[<p>[...] our story on this Fremont, Calif., biotech in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; FlowCardia raises $30M for artery roto-rooters</title>
		<link>http://venturebeat.com/2007/08/31/life-sciences-briefing-friday-aug-31-2007/comment-page-1/#comment-502224</link>
		<dc:creator>VentureBeat &#187; FlowCardia raises $30M for artery roto-rooters</dc:creator>
		<pubDate>Fri, 31 Aug 2007 17:59:58 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/08/31/life-sciences-briefing-friday-aug-31-2007/#comment-502224</guid>
		<description>[...] our story on this Sunnyvale, Calif., medical-device maker in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</description>
		<content:encoded><![CDATA[<p>[...] our story on this Sunnyvale, Calif., medical-device maker in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
